Demineralized Bone Matrix as a Carrier for Bone Morphogenetic Protein-2: Burst Release Combined with Long-Term Binding and Osteoinductive Activity Evaluated In Vitro and In Vivo

To allow bone defect regeneration, autologous bone grafting still represents the gold standard. However, autograft harvesting has limitations, including an additional surgery, donor site morbidity, and limited availability. Demineralized bone matrix (DBM) would represent an alternative, yet lacks su...

Full description

Saved in:
Bibliographic Details
Published in:Tissue engineering. Part A 2017-12, Vol.23 (23-24), p.1321-1330
Main Authors: Huber, Elisabeth, Pobloth, Anne-Marie, Bormann, Nicole, Kolarczik, Nicolai, Schmidt-Bleek, Katharina, Schell, Hanna, Schwabe, Philipp, Duda, Georg N., Wildemann, Britt
Format: Article
Language:English
Subjects:
Acids
Autografts
Binding sites
Biological activity
Bone grafts
Bone growth
Bone healing
Bone matrix
Bone morphogenetic protein 2
Bone surgery
Defects
Demineralizing
Elution
Grafting
Growth factors
Morbidity
Osteogenesis
Proteins
Regeneration
Sheep
Special Focus Articles
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To allow bone defect regeneration, autologous bone grafting still represents the gold standard. However, autograft harvesting has limitations, including an additional surgery, donor site morbidity, and limited availability. Demineralized bone matrix (DBM) would represent an alternative, yet lacks sufficient osteoinductive properties. Combining DBM with a potent agent, such as bone morphogenetic protein-2 (BMP-2) might be a feasible alternative approach, optimizing an established grafting material with strong osteoinductive properties. A unique mixing device has been developed that enables perioperative handling to reach a homogeneous and standardized paste for bone defect filling. DBM proved in vitro to be a suitable carrier for BMP-2, with a documented release over 56 days at concentrations sufficient to stimulate osteogenic differentiation. At the end of the elution experiment, 56 days, bioactive BMP was still captured within the DBM. Using a sheep drill hole defect model, DBM perioperatively mixed with BMP-2 showed strong osteoinductive properties comparable to those of autologous bone and outnumbering the one of DBM alone or empty defects. Bone defect healing was enabled at diaphyseal and metaphyseal defects and thus BMP-2-doped DBM represented an easy perioperative enriching method and an efficient carrier for BMP-2. With the comparability to the clinical gold standard autologous bone, DBM mixed with BMP-2 might serve as possible alternative grafting material enabling a controlled osteogenic stimulation.
ISSN:1937-3341
1937-335X
DOI:10.1089/ten.tea.2017.0005